136 related articles for article (PubMed ID: 17949227)
1. Modulation of HLA-G expression.
Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
[TBL] [Abstract][Full Text] [Related]
2. HLA-G gene repression is reversed by demethylation.
Moreau P; Mouillot G; Rousseau P; Marcou C; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1191-6. PubMed ID: 12552087
[TBL] [Abstract][Full Text] [Related]
3. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
Poláková K; Bandzuchová E; Kuba D; Russ G
Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
[TBL] [Abstract][Full Text] [Related]
4. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells.
Teklemariam T; Purandare B; Zhao L; Hantash BM
Biochem Biophys Res Commun; 2014 Sep; 452(3):753-9. PubMed ID: 25204503
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
[TBL] [Abstract][Full Text] [Related]
7. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta.
Guillaudeux T; Rodriguez AM; Girr M; Mallet V; Ellis SA; Sargent IL; Fauchet R; Alsat E; Le Bouteiller P
J Immunol; 1995 Apr; 154(7):3283-99. PubMed ID: 7897212
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.
Yang Y; Chu W; Geraghty DE; Hunt JS
J Immunol; 1996 Jun; 156(11):4224-31. PubMed ID: 8666791
[TBL] [Abstract][Full Text] [Related]
9. RREB-1 is a transcriptional repressor of HLA-G.
Flajollet S; Poras I; Carosella ED; Moreau P
J Immunol; 2009 Dec; 183(11):6948-59. PubMed ID: 19890057
[TBL] [Abstract][Full Text] [Related]
10. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia modulates HLA-G gene expression in tumor cells.
Mouillot G; Marcou C; Zidi I; Guillard C; Sangrouber D; Carosella ED; Moreau P
Hum Immunol; 2007 Apr; 68(4):277-85. PubMed ID: 17400064
[TBL] [Abstract][Full Text] [Related]
12. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Fujii T; Ishitani A; Geraghty DE
J Immunol; 1994 Dec; 153(12):5516-24. PubMed ID: 7989753
[TBL] [Abstract][Full Text] [Related]
13. Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
Du HL; Ren LM; Chen H; Zhu Y; Qi Y
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):981-4. PubMed ID: 12433622
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
Adair SJ; Hogan KT
Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715
[TBL] [Abstract][Full Text] [Related]
15. Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Polakova K; Bandzuchova E; Sabty FA; Mistrik M; Demitrovicova L; Russ G
Neoplasma; 2009; 56(6):514-20. PubMed ID: 19728760
[TBL] [Abstract][Full Text] [Related]
16. HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.
Boucraut J; Guillaudeux T; Alizadeh M; Boretto J; Chimini G; Malecaze F; Semana G; Fauchet R; Pontarotti P; Le Bouteiller P
Immunogenetics; 1993; 38(2):117-30. PubMed ID: 7683306
[TBL] [Abstract][Full Text] [Related]
17. HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis.
Moreau P; Teyssier M; Kirszenbaum M; Gluckman E; Gourand L; Carosella E; Dausset J
Folia Biol (Praha); 1994; 40(6):431-8. PubMed ID: 7589701
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
